David P. Recker

2.2k total citations
36 papers, 1.7k citations indexed

About

David P. Recker is a scholar working on Pharmacology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David P. Recker has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 11 papers in Surgery and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David P. Recker's work include Inflammatory mediators and NSAID effects (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Anesthesia and Pain Management (5 papers). David P. Recker is often cited by papers focused on Inflammatory mediators and NSAID effects (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Anesthesia and Pain Management (5 papers). David P. Recker collaborates with scholars based in United States, United Kingdom and South Africa. David P. Recker's co-authors include Kenneth M. Verburg, Jeffrey D. Kent, William W. Zhao, Paul J. Desjardins, John Ilgenfritz, Daniël B.F. Saris, Sheela Talwalker, Mats Brittberg, Philip T. Leese and Frédéric Camu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

David P. Recker

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David P. Recker United States 21 749 663 297 260 231 36 1.7k
Michaele B. Manigrasso United States 20 341 0.5× 300 0.5× 190 0.6× 152 0.6× 124 0.5× 33 1.7k
James A. Burke United States 28 999 1.3× 128 0.2× 311 1.0× 603 2.3× 34 0.1× 78 2.7k
Qin Zhang China 24 403 0.5× 99 0.1× 454 1.5× 244 0.9× 86 0.4× 102 2.2k
Fania Szlam United States 32 938 1.3× 165 0.2× 192 0.6× 899 3.5× 25 0.1× 105 3.3k
Akiko Tanaka United States 22 859 1.1× 350 0.5× 180 0.6× 571 2.2× 67 0.3× 141 1.9k
Dolores B. Njoku United States 19 308 0.4× 73 0.1× 140 0.5× 330 1.3× 55 0.2× 51 1.5k
Marie–Françoise Doursout United States 20 385 0.5× 61 0.1× 261 0.9× 355 1.4× 17 0.1× 74 1.6k
D. B. Frewin Australia 18 265 0.4× 64 0.1× 220 0.7× 281 1.1× 37 0.2× 91 1.2k
Carmela Aloisi Italy 25 251 0.3× 98 0.1× 248 0.8× 144 0.6× 66 0.3× 62 1.7k
Jin Hyun Kim South Korea 24 208 0.3× 71 0.1× 158 0.5× 62 0.2× 112 0.5× 79 1.6k

Countries citing papers authored by David P. Recker

Since Specialization
Citations

This map shows the geographic impact of David P. Recker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Recker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Recker more than expected).

Fields of papers citing papers by David P. Recker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Recker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Recker. The network helps show where David P. Recker may publish in the future.

Co-authorship network of co-authors of David P. Recker

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Recker. A scholar is included among the top collaborators of David P. Recker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Recker. David P. Recker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hickerson, William L., Ann E. Remmers, & David P. Recker. (2018). Twenty-Five Years’ Experience and Beyond with Cultured Epidermal Autografts for Coverage of Large Burn Wounds in Adult and Pediatric Patients, 1989–2015. Journal of Burn Care & Research. 40(2). 157–165. 23 indexed citations
3.
Henry, Timothy D., Amit N. Patel, Gary L. Schaer, et al.. (2016). TCT-824 Reduction in Ventricular Arrhythmias with Ixmyelocel-T: Results from the IxCell-DCM Trial. Journal of the American College of Cardiology. 68(18). B333–B334. 1 indexed citations
4.
Henry, Timothy D., Arshed A. Quyyumi, Gary L. Schaer, et al.. (2016). THE FINAL RESULTS OF THE IXCELL-DCM TRIAL: TRANSENDOCARDIAL INJECTION OF IXMYELOCEL-T IN PATIENTS WITH ISCHEMIC DILATED CARDIOMYOPATHY. Journal of the American College of Cardiology. 67(13). 1447–1447. 1 indexed citations
5.
Patel, Amit N., Timothy D. Henry, Arshed A. Quyyumi, et al.. (2016). Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. The Lancet. 387(10036). 2412–2421. 113 indexed citations
6.
Reynolds, Lowell W., et al.. (2003). The COX-2 Specific Inhibitor, Valdecoxib, Is An Effective, Opioid-Sparing Analgesic in Patients Undergoing Total Knee Arthroplasty. Journal of Pain and Symptom Management. 25(2). 133–141. 51 indexed citations
7.
Goldstein, Jay L., et al.. (2003). A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects. Alimentary Pharmacology & Therapeutics. 18(1). 125–132. 40 indexed citations
8.
Leese, Philip T., David P. Recker, & Jeffrey D. Kent. (2003). The COX-2 Selective Inhibitor, Valdecoxib, Does Not Impair Platelet Function in the Elderly: Results of a Randomized Controlled Trial. The Journal of Clinical Pharmacology. 43(5). 504–513. 5 indexed citations
9.
Kivitz, Alan, et al.. (2002). Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.. PubMed. 51(6). 530–7. 89 indexed citations
10.
Fricke, James R., et al.. (2002). Valdecoxib Is More Efficacious Than Rofecoxib in Relieving Pain Associated With Oral Surgery. American Journal of Therapeutics. 9(2). 89–97. 67 indexed citations
11.
12.
Sikes, David, Naurang M. Agrawal, William W. Zhao, et al.. (2002). Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis. European Journal of Gastroenterology & Hepatology. 14(10). 1101–1111. 88 indexed citations
13.
Daniels, Stephen E., Paul J. Desjardins, Sheela Talwalker, David P. Recker, & Kenneth M. Verburg. (2002). The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery. The Journal of the American Dental Association. 133(5). 611–621. 99 indexed citations
14.
Camu, Frédéric, et al.. (2002). Valdecoxib, a COX-2???Specific Inhibitor, Is an Efficacious, Opioid-Sparing Analgesic in Patients Undergoing Hip Arthroplasty. American Journal of Therapeutics. 9(1). 43–51. 118 indexed citations
15.
Leese, Philip T., Sheela Talwalker, Jeffrey D. Kent, & David P. Recker. (2002). Valdecoxib does not impair platelet function. The American Journal of Emergency Medicine. 20(4). 275–281. 72 indexed citations
16.
Goldstein, Jay L., Kaffa Fakouhi, William W. Zhao, et al.. (2001). Reduced incidence of gastroduodenal ulcers with valdecoxib compared to ibuprofen and diclofenac in patients with osteoarthritis: A multicenter trial. Gastroenterology. 120(5). A597–A597. 7 indexed citations
17.
Recker, David P., et al.. (1991). A Monocyte-Derived Factor Interferes with Detection of Reverse Transcriptase in HIV-1 Infection. AIDS Research and Human Retroviruses. 7(1). 73–81. 5 indexed citations
18.
Gimble, Jeffrey M., James R. Flanagan, David P. Recker, & Edward E. Max. (1988). Identification and partial purification of a protein binding to the human immunoglobulin kappa enhancerxE2 site. Nucleic Acids Research. 16(11). 4967–4988. 8 indexed citations
19.
Recker, David P., et al.. (1981). Enhanced purine salvage during allopurinol therapy: an important pharmacologic property in humans.. PubMed. 98(5). 673–83. 35 indexed citations
20.
Edwards, N. Lawrence, David P. Recker, & Irving H. Fox. (1980). Hypoxanthine Salvage in Man: Its Importance in Urate Overproduction in the Lesch-Nyhan Syndrome. Advances in experimental medicine and biology. 122A. 301–306. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michaele B. Manigrasso Breakdown of academic impact, for papers by James A. Burke Breakdown of academic impact, for papers by Qin Zhang Breakdown of academic impact, for papers by Fania Szlam Breakdown of academic impact, for papers by Akiko Tanaka Breakdown of academic impact, for papers by Dolores B. Njoku Breakdown of academic impact, for papers by Marie–Françoise Doursout Breakdown of academic impact, for papers by D. B. Frewin Breakdown of academic impact, for papers by Carmela Aloisi Breakdown of academic impact, for papers by Jin Hyun Kim
Rankless by CCL
2026